●TSLP: finally in the limelight. Leonard, W. J. Nature Immunology July (2002) A News and Views article that describes a recently identified role for human thymic stromal lymphopoietin at an early stage of the allergic immune response.

●May the force be with you: myosin-X in phagocytosis. Chavrier, P. Nature Cell Biology July (2002)

●CD8+ T-cell responses: it's all downhill after their prime... Blattman, J. N., Cheng, L. E. & Greenberg, P. D. Nature Immunology July (2002)

●Identification of tumour-associated T-cell epitopes for vaccine development. Stevanovic, S. Nature Reviews Cancer July (2002) This review discusses how tumour-specific T-cell epitopes can be identified and how their efficacy as anticancer treatments can be improved.

●RNA interference meets HIV-1: will silence be golden? Pomerantz, R. J. Nature Medicine July (2002) This News and Views article discusses RNAi and new research that indicates that this technology might be applied to the development of new antiviral therapies.

●The great primate debate. Goodman, S. & Check, E. Nature 13 June (2002) This news feature discusses how public opinion and regulations regarding experimentation on primates differ between countries. How will these differences affect current and future biomedical research — for example, research into HIV vaccines — that rely on these primate models?

●Core binding factor in haematopoiesis and leukaemia. Speck, N. A. & Gilliland, D. G. Nature Reviews Cancer July (2002) A review article that discusses how the core binding factor (CBF) family of heterodimeric transcription factors regulates haematopoiesis, and how these processes can go wrong in leukaemia.

●Magic bullets hit the target. Gura, T. Nature 6 June (2002) A news feature on the development of monoclonal antibodies as drugs, and the hope and disappointment that has surrounded the pursuit of this goal.